Streptococcus pneumoniae endophthalmitis: A study of 36 cases with special reference to antibiotic resistance and treatment options

Clinical Microbiology and Infection

Volumn 12, Issue 6, 2006, Pages 519-526

  Soriano, F ^a   Perez Trallero E ^b   Pallares R ^c   Meseguer, M A ^d   Fleites, A ^e   Gene A ^f   Gonzalez A ^b   Linares J ^c   Esteban, J ^a   Baquero, F ^d   Valdes E ^e   Munoz Almagro C ^f  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Antibiotic resistance; Cataract surgery; Endogenous infection; Endophthalmitis; Streptococcus pneumoniae; Therapy

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFADROXIL; CEFALORIDINE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AQUEOUS HUMOR; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLONE; DISEASE COURSE; DRUG CHOICE; EMERGENCY CARE; ENDOPHTHALMITIS; ENUCLEATION; EYE INJURY; EYE SURGERY; FEMALE; HUMAN; INFECTION RISK; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RADIOTHERAPY; RETROSPECTIVE STUDY; SEROTYPE; SEX RATIO; SPAIN; STREPTOCOCCUS PNEUMONIAE; SWEDEN; TREATMENT FAILURE; VISUAL DISORDER; VISUAL SYSTEM EXAMINATION; VITREOUS BODY;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 33646760997     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01418.x     Document Type: Article

References (61)

1. Sunaric-Mégevand G, Pournaras CJ. Current approach to postoperative endophthalmitis. Br J Ophthalmol 1997; 81: 1006-1015.
2. Salvanet-Bouccara A, Dubayle P, Forestier F, Dublanchet A, Antiphon P, Lafaix C. Pneumococcal postoperative endophthalmitis. J Fr Opthalmol 1984; 7: 535-538.
3. Gus RB, Koenig S, De la Pena W, Marx M, Kaufman HE. Endophthalmitis after penetrating keratoplasty. Am J Opthalmol 1983; 95: 651-658.
4. Heaven CJ, Mann PJ, Boase DL. Endophthalmitis following extracapsular cataract surgery: A review of 32 cases. Br J Ophthalmol 1992; 76: 419-423.
5. Allen HF, Mangiaracine AB. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol 1974; 91: 3-7.
6. Han DP, Wisniewski SR, Wilson LA et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996; 122: 1-17.
7. Miller JJ, Scott IU, Flynn HW, Smiddy WE, Corey RP, Miller D. Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 2004; 138: 231-236.
8. Baum J, Peyman GA, Barza M. Intravitreal administration of antibiotics in the treatment of bacterial endophthalmitis. III. Consensus. Surv Ophthalmol 1982; 26: 204-206.
9. Brod RD, Flynn HW. Endophthalmitis: Current approaches to diagnosis and therapy. Curr Opin Infect Dis 1993; 6: 628-637.
10. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1995; 113: 1479-1496.
11. Vahey JB, Flynn HW. Results in the management of Bacillus endophthalmitis. Ophthal Surg 1991; 22: 681-686.
12. Seal DV, Barrett SP, McGill JI. Aetiology and treatment of acute bacterial infection of the external eye. Br J Ophthalmol 1982; 66: 357-360.
13. López PF, Beldavs RA, al-Ghamdi S et al. Pneumococcal endophthalmitis associated with nasolacrimal obstruction. Am J Ophthalmol 1993; 116: 56-62.
14. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds, Manual of clinical microbiology, 8th edn. Washington, DC: ASM Press, 2003; 405-421.
15. 14-5). Microb Drug Resist 2003; 9: 133-137.
16. Mao LK, Flynn HW, Miller D, Pflugfelder SC. Endophthalmitis caused by streptococcal species. Arch Ophthalmol 1992; 110: 798-801.
17. Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: Epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev 2002; 15: 111-124.
18. Winward KE, Pflugfelder SC, Flynn HW, Roussel TJ, Davis JL. Postoperative Propionibacterium endophthalmitis. Treatment strategies and long-term results. Ophthalmology 1993; 100: 447-451.
19. Davis JL, Koidou-Tsiligianni A, Pflugfelder SC, Miller D, Flynn HW, Forster RK. Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance. Ophthalmology 1988; 95: 1404-1410.
20. Clark WL, Kaiser PK, Flynn HW, Belfort A, Miller D, Meisler DM. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999; 106: 1665-1670.
21. Matoba A, Moore MB, Merten JL, McCulley JP. Donor-to-host transmission of streptococcal infection by cornea stored in McCarey-Kaufman medium. Cornea 1984; 3: 105-108.
22. Khodadoust AA, Franklin RM. Transfer of bacterial infections by donor cornea penetrating keratoplasty. Am J Ophthalmol 1979; 87: 130-132.
23. Baer JC, Nirankari VS, Glaros DS. Streptococcal endophthalmitis from contaminated donor corneas after keratoplasty. Clinical and laboratory investigations. Arch Ophthalmol 1988; 106: 517-520.
24. Buzard K, Liapis S. Prevention of endophthalmitis. J Cataract Refract Surg 2004; 30: 1953-1959.
25. Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis 2004; 38: 542-546.
26. Almeda EM. Metastatic pneumococcic endophthalmitis. Am J Ophthalmol 1960; 49: 353-355.
27. Jarret WH, Wells JA, Hyman BN. Metastatic endophthalmitis: A report of three cases in proven septicaemia. South Med J 1971; 64: 194-198.
28. Weintraub MI, Otto RN. Pneumococcal meningitis and endophthalmitis in a newborn. JAMA 1972; 219: 1763-1764.
29. Gregg CR, Tucker WS. Acute endogenous endophthalmitis after splenectomy. J Tenn Med Assoc 1985; 78: 25-26.
30. Farber BP, Weinbaum DL, Dummen JS. Metastatic bacterial endophthalmitis. Arch Intern Med 1985; 145: 62-64.
31. Cheesbrough JS, Williams CL, Rustom R, Bucknall RC, Trimble RB. Metastatic pneumococcal endophthalmitis: Report of two cases and review of literature. J Infect 1990; 20: 231-236.
32. De Groot V, Stempels N, Tassignon MJ. Endogenous pneumococcal endophthalmitis after splenectomy: Report of two cases. Bull Soc Belge Ophtalmol 1992; 243: 147-151.
33. Romero CF, Rai MK, Lowder CY, Adal KA. Endogenous endophthalmitis: Case report and brief review. Am Fam Physician 1999; 60: 510-514.
34. Rubin RH, King ME, Mark EJ. Case record of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2003. A 43-year-old man with fever, rapid loss of vision in the left eye, and cardiac findings. N Engl J Med 2003; 348: 834-843.
35. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003; 48: 403-423.
36. Nessi F, Bovey EH, Guex-Crosier Y. Endogenous pneumococcal endophthalmitis followed by pneumococcal-induced uveitis. Klin Monatsbl Augenheilkd 2003; 220: 204-206.
37. Christensen SR, Hansen A-BE, La Cour M, Fledelius HC. Bilateral endogenous endophthalmitis: A report of four cases. Acta Ophthalmol Scand 2004; 82: 306-310.
38. Stevens SX, Fouraker BD, Jensen HG. Intraocular safety of ciprofloxacin. Arch Ophthalmol 1991; 109: 1737-1743.
39. Wiechens B, Grammer JB, Johannsen U, Pleyer U, Hedderich J, Duncker GI. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 1999; 213: 120-128.
40. Unal M, Peyman GA, Liang C et al. Ocular toxicity of intravitreal clarithromycin. Retina 1999; 19: 442-446.
41. Derik RJ, Paylor R, Peyman GA. Toxicity of imipenem in vitreous replacement fluid. Ann Ophthalmol 1987; 19: 338-339.
42. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injections in humans. Arch Ophthalmol 1993; 111: 492-494.
43. Rubinstein E, Triester G, Avni I, Schwartzkopf R. The intravitreal penetration of cefotaxime in man following systemic and subconjunctival administrations. Ophthalmology 1987; 94: 30-34.
44. Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998; 105: 1004-1010.
45. Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol 1999; 117: 1023-1027.
46. Meredith TA, Aguilar HE, Shaarawy A, Kincaid M, Dick J, Niesman MR. Vancomycin levels in the vitreous cavity after intravenous administration. Am J Ophthalmol 1995; 119: 774-778.
47. Aguilar HE, Meredith TA, Shaarawy A, Kincaid M, Dick J. Vitreous cavity penetration of ceftazidime after intravenous administration. Retina 1995; 15: 154-159.
48. Liñares J, Alonso T, Pérez JL et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-288.
49. Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Diagn Microbiol Infect Dis 2000; 37: 93-98.
50. Sharir M, Triester G, Kneer J, Rubinstein E. The intravitreal penetration of ceftriaxone in man following systemic administration. Invest Ophthalmol Vis Sci 1989; 30: 2179-2183.
51. Adenis JP, Mounier M, Salomon JL, Denis F. Human vitreous penetration of imipenem. Eur J Ophthalmol 1994; 4: 115-117.
52. Axelrod JL, Newton JC, Klein RM, Bergen RL, Sheikh MZ. Penetration of imipenem into human aqueous and vitreous humor. Am J Ophthalmol 1987; 104: 649-653.
53. el Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992; 99: 483-486.
54. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 2003; 121: 345-350.
55. Kampougeris G, Antoniadou A, Kavouklis E, Chryssouli Z, Giamarellou H. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol 2005; 89: 628-631.
56. Wong KW, D'Amico DJ, Oum BS, Baker PA, Kenyon KR. Intraocular penetration of rifampin after oral administration. Graefes Arch Clin Exp Ophthalmol 1990; 228: 40-43.
57. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1995; 113: 1324-1329.
58. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective randomised study. Br J Ophthalmol 1999; 83: 1050-1055.
59. Javitt JC, Street DA, Tielsch JM et al. National outcomes of cataract extraction. Retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 1994; 101: 100-106.
60. Shah GK, Stein JD, Sharma S et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000; 107: 486-489.
61. Meredith TA, Aguilar HE, Drews C et al. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc 1996; 94: 241-252.